Suppr超能文献

丹参酮 IIA 磺酸钠通过调节 A20-NFκB-NLRP3 炎性小体-过氧化氢酶通路减轻糖尿病小鼠血管衰老。

Sodium Tanshinone IIA Sulfonate alleviates vascular senescence in diabetic mice by modulating the A20-NFκB-NLRP3 inflammasome-catalase pathway.

机构信息

Department of Pharmacology, Changzhi Medical College, No.161, Jiefang East Street, Changzhi, 046000, Shanxi, China.

Department of Endocrinology and Institute of Endocrinology and Metabolic Disease, Heping Hospital Affiliated to Changzhi Medical College, No.110, Yanan Road South, Changzhi, 046000, Shanxi, China.

出版信息

Sci Rep. 2024 Jul 26;14(1):17665. doi: 10.1038/s41598-024-68169-1.

Abstract

Diabetes accelerates vascular senescence, which is the basis for atherosclerosis and stiffness. The activation of NOD-like receptor family pyrin domain containing 3 (NLRP3) inflammasome and oxidative stress are closely associated with the deteriorative senescence in endothelial cells (ECs) and vascular smooth muscle cells (VSMCs). For decades, Sodium Tanshinone IIA Sulfonate (STS) has been utilized as a cardiovascular medicine with acknowledged anti-inflammatory and anti-oxidative properties. Nevertheless, the impact of STS on vascular senescence remains unexplored in diabetes. Diabetic mice, primary ECs and VSMCs were transfected with the NLRP3 overexpression/knockout plasmid, the tumor necrosis factor alpha-induced protein 3 (TNFAIP3/A20) overexpression/knockout plasmid, and treated with STS to detect senescence-associated markers. In diabetic mice, STS treatment maintained catalase (CAT) level and vascular relaxation, reduced hydrogen peroxide probe (ROSgreen) fluorescence, p21 immunofluorescence, Senescence β-Galactosidase Staining (SA-β-gal) staining area, and collagen deposition in aortas. Mechanistically, STS inhibited NLRP3 phosphorylation (serine 194), NLRP3 dimer formation, NLRP3 expression, and NLRP3-PYCARD (ASC) colocalization. It also suppressed the phosphorylation of IkappaB alpha (IκBα) and NFκB, preserved A20 and CAT levels, reduced ROSgreen density, and decreased the expression of p21 and SA-β-gal staining in ECs and VSMCs under HG culture. Our findings indicate that STS mitigates vascular senescence by modulating the A20-NFκB-NLRP3 inflammasome-CAT pathway in hyperglycemia conditions, offering novel insights into NLRP3 inflammasome activation and ECs and VSMCs senescence under HG culture. This study highlights the potential mechanism of STS in alleviating senescence in diabetic blood vessels, and provides essential evidence for its future clinical application.

摘要

糖尿病加速血管衰老,这是动脉粥样硬化和僵硬的基础。NOD 样受体家族含pyrin 结构域蛋白 3(NLRP3)炎症小体的激活和氧化应激与内皮细胞(ECs)和血管平滑肌细胞(VSMCs)恶化的衰老密切相关。几十年来,丹参酮 IIA 磺酸钠(STS)一直被用作具有公认抗炎和抗氧化特性的心血管药物。然而,STS 对糖尿病血管衰老的影响仍未被探索。用 NLRP3 过表达/敲除质粒、肿瘤坏死因子α诱导蛋白 3(TNFAIP3/A20)过表达/敲除质粒转染糖尿病小鼠、原代 ECs 和 VSMCs,并给予 STS 处理,以检测衰老相关标志物。在糖尿病小鼠中,STS 治疗维持过氧化氢酶(CAT)水平和血管舒张,减少过氧化氢探针(ROSgreen)荧光、p21 免疫荧光、衰老 β-半乳糖苷酶染色(SA-β-gal)染色面积和主动脉胶原沉积。在机制上,STS 抑制 NLRP3 磷酸化(丝氨酸 194)、NLRP3 二聚体形成、NLRP3 表达和 NLRP3-PYCARD(ASC)共定位。它还抑制 IkappaB alpha(IκBα)和 NFκB 的磷酸化,维持 A20 和 CAT 水平,减少 ROSgreen 密度,并降低 HG 培养下 ECs 和 VSMCs 中 p21 和 SA-β-gal 染色的表达。我们的研究结果表明,STS 通过调节高糖条件下的 A20-NFκB-NLRP3 炎症小体-CAT 通路减轻血管衰老,为 NLRP3 炎症小体激活和 HG 培养下 ECs 和 VSMCs 衰老提供了新的见解。这项研究强调了 STS 缓解糖尿病血管衰老的潜在机制,并为其未来的临床应用提供了重要证据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70af/11291694/aa7ac53dd1f8/41598_2024_68169_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验